Olaparib beim metastasierten Prostatakarzinom – die PROfound-Studie

Axel S. Merseburger

doi:10.1007/s00120-020-01306-6

Olaparib beim metastasierten Prostatakarzinom – die PROfound-Studie

Translated title of the contribution: Olaparib for metastatic prostate cancer—the PROfound trial

Axel S. Merseburger^*

^*Corresponding author for this work

Clinic of Urology

1 Citation (Scopus)

Translated title of the contribution	Olaparib for metastatic prostate cancer—the PROfound trial
Original language	German
Journal	Urologe
Volume	59
Issue number	10
Pages (from-to)	1249-1250
Number of pages	2
ISSN	0340-2592
DOIs	https://doi.org/10.1007/s00120-020-01306-6
Publication status	Published - 01.10.2020

Research Areas and Centers

Research Area: Luebeck Integrated Oncology Network (LION)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00120-020-01306-6

Cite this

@article{95c9e1c4d34846b39a2a02509842108f,

title = "Olaparib beim metastasierten Prostatakarzinom – die PROfound-Studie",

author = "Merseburger, {Axel S.}",

year = "2020",

month = oct,

day = "1",

doi = "10.1007/s00120-020-01306-6",

language = "Deutsch",

volume = "59",

pages = "1249--1250",

journal = "Urologe",

issn = "0340-2592",

number = "10",

}

TY - JOUR

T1 - Olaparib beim metastasierten Prostatakarzinom – die PROfound-Studie

AU - Merseburger, Axel S.

PY - 2020/10/1

Y1 - 2020/10/1

UR - http://www.scopus.com/inward/record.url?scp=85089365059&partnerID=8YFLogxK

U2 - 10.1007/s00120-020-01306-6

DO - 10.1007/s00120-020-01306-6

M3 - Kommentare/Debatten

C2 - 32785732

AN - SCOPUS:85089365059

SN - 0340-2592

VL - 59

SP - 1249

EP - 1250

JO - Urologe

JF - Urologe

IS - 10

ER -

Olaparib beim metastasierten Prostatakarzinom – die PROfound-Studie

Research Areas and Centers

UN SDGs

Access to Document

Other files and links

Cite this